Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment options for sleep apnoea.

R R Grunstein1, J Hedner, L Grote

  • 1Centre for Respiratory Failure and Sleep Disorders, Royal Prince Alfred Hospital and University of Sydney, Australia. rrg@mail.med.usyd.edu.au

Drugs
|March 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The future of education in sleep science and medicine in Europe: Report of an ESRS workshop.

Journal of sleep research·2025
Same author

Sleep apnoea phenotypes in women: A cluster analysis from the ESADA cohort.

Sleep medicine·2024
Same author

Sleep-disordered breathing in severe mental illness: clinical evaluation of oximetry diagnosis and management limitations.

Sleep & breathing = Schlaf & Atmung·2020
Same author

EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke.

European journal of neurology·2020
Same author

Hyperlipidaemia prevalence and cholesterol control in obstructive sleep apnoea: Data from the European sleep apnea database (ESADA).

Journal of internal medicine·2019
Same author

Insomnia symptoms combined with nocturnal hypoxia associate with cardiovascular comorbidity in the European sleep apnea cohort (ESADA).

Sleep & breathing = Schlaf & Atmung·2018

Sleep apnoea (SA), a common disorder causing airway obstruction during sleep, impacts vigilance and quality of life. Current treatments like CPAP have low compliance, highlighting the need for better management strategies.

Area of Science:

  • Sleep Medicine
  • Respiratory Medicine
  • Cardiovascular Medicine

Background:

  • Sleep apnoea (SA) affects 4-25% of adults, with obstructive SA being most common.
  • Characterized by recurrent upper airway obstruction, sleep disruption, and hypoxaemia during sleep.
  • SA is linked to impaired vigilance, reduced quality of life, increased accidents, and potential vascular disease risk.

Purpose of the Study:

  • To review the current understanding of sleep apnoea.
  • To discuss established and emerging treatment modalities for SA.
  • To highlight challenges in current SA management, particularly CPAP noncompliance.

Main Methods:

  • Literature review of sleep apnoea prevalence, pathophysiology, and treatment options.
  • Analysis of evidence regarding the impact of SA on health and safety.

Related Experiment Videos

  • Examination of current therapeutic interventions, including continuous positive airway pressure (CPAP), surgery, and oral appliances.

    • Main Results:

    • Obstructive SA involves airway obstruction, sleep disruption, and hypoxaemia.
    • SA negatively affects cognitive function, daily living, and poses vascular risks.
    • CPAP is the primary treatment for moderate to severe SA, but noncompliance rates approach 50%.

    Conclusions:

    • Effective treatments for SA focus on maintaining upper airway patency.
    • Significant challenges exist with current SA treatments, especially CPAP adherence.
    • Pharmacological treatments are not yet indicated for moderate to severe SA, necessitating further research.